Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
Neurology|February 12, 2004
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled studyF Durif, B Debilly, M Galitzky, et al.
The New England Journal of Medicine|May 18, 2000
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopaO Rascol, D J Brooks, A D Korczyn, et al.
Clinical Neuropharmacology|October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollisC Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2001
Within-session and between-session reproducibility of cerebral sensorimotor activation: a test--retest effect evidenced with functional magnetic resonance imagingI Loubinoux, C Carel, F Alary, et al.
Neuroimage. Clinical|May 26, 2019
A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy controlF Nemmi, A Pavy-Le Traon, O R Phillips, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow upP Pollak, F Tison, O Rascol, et al.
Parkinsonism & Related Disorders|February 10, 2012
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trialO Rascol, J Bronzova, R A Hauser, et al.
European Neurology|May 2, 2009
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's diseaseR A Hauser, J Bronzova, C Sampaio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's diseaseO Rascol, U Sabatini, N Fabre, et al.
Clinical Neuropharmacology|April 1, 1989
A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepineO Rascol, A Squalli, J L Montastruc, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Neurology|February 12, 2004
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled studyF Durif, B Debilly, M Galitzky, et al.
The New England Journal of Medicine|May 18, 2000
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopaO Rascol, D J Brooks, A D Korczyn, et al.
Clinical Neuropharmacology|October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollisC Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2001
Within-session and between-session reproducibility of cerebral sensorimotor activation: a test--retest effect evidenced with functional magnetic resonance imagingI Loubinoux, C Carel, F Alary, et al.
Neuroimage. Clinical|May 26, 2019
A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy controlF Nemmi, A Pavy-Le Traon, O R Phillips, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow upP Pollak, F Tison, O Rascol, et al.
Parkinsonism & Related Disorders|February 10, 2012
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trialO Rascol, J Bronzova, R A Hauser, et al.
European Neurology|May 2, 2009
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's diseaseR A Hauser, J Bronzova, C Sampaio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's diseaseO Rascol, U Sabatini, N Fabre, et al.
Clinical Neuropharmacology|April 1, 1989
A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepineO Rascol, A Squalli, J L Montastruc, et al.
Pageof 22